Published in Gut on August 01, 1998
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol (2003) 1.23
Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol (2001) 1.22
Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study. J Clin Microbiol (2014) 1.20
Molecular mechanisms of H. pylori associated gastric carcinogenesis. World J Gastroenterol (1999) 1.15
Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Mol Pathol (2003) 1.07
Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front Cell Infect Microbiol (2012) 0.96
Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol (2003) 0.95
Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan. World J Gastroenterol (2004) 0.94
Role of bacterial and genetic factors in gastric cancer in Costa Rica. World J Gastroenterol (2009) 0.91
H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci (2010) 0.89
Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol (2005) 0.89
Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies. Clin Diagn Lab Immunol (2000) 0.88
The "Costa Rican enigma" of Helicobacter pylori CagA and gastric cancer. J Gastroenterol (2006) 0.79
The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria. Gastroenterol Res Pract (2013) 0.79
Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. Helicobacter (2014) 0.78
Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China. Chin J Cancer Res (2017) 0.75
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70
Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res (1995) 3.30
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
The vacuolating cytotoxin of Helicobacter pylori. Mol Microbiol (1996) 3.08
Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology (1996) 3.00
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut (1994) 2.10
Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res (1996) 1.89
Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol (1993) 1.77
Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut (1994) 1.49
Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol (1996) 1.34
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut (1994) 1.19
IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer (1996) 1.16
Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol (1995) 1.04
Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol (1996) 1.04
Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl (1996) 0.99
High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer (1994) 0.99
Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventative factors? Nutr Rev (1994) 0.97
Helicobacter pylori and early gastric cancer. Gut (1994) 0.96
Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer (1994) 0.95
Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology. Am J Gastroenterol (1998) 0.85
Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol (1997) 0.85
Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection. Helicobacter (1996) 0.85
Helicobacter pylori and gastric carcinogenesis. Scand J Gastroenterol Suppl (1996) 0.81
Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens. Cancer (1996) 0.81
Reversal of multidrug resistance in cancer cells. J Natl Cancer Inst (1994) 0.78
Detection of Helicobacter pylori in biopsy of patients with gastric carcinoma. Biomed Pharmacother (1997) 0.77
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology (1994) 3.15
The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl (1996) 2.18
Fluvastatin treatment is not associated with an increased incidence of cancer. Int J Clin Pract (2006) 2.13
Restoration of fertility by in-vitro spermatogenesis. Lancet (1999) 2.10
In-vitro maturation of immature human male germ cells. Mol Cell Endocrinol (2000) 2.04
Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study. Pain (2008) 1.79
Trigeminal neuralgia and pain related to multiple sclerosis. Pain (2009) 1.71
Hot-electron nanoscopy using adiabatic compression of surface plasmons. Nat Nanotechnol (2013) 1.68
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Cardiac troponin I, cardiac troponin T and creatine kinase MB concentrations in umbilical cord blood of healthy term neonates. Acta Paediatr (2003) 1.64
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. Dig Liver Dis (2000) 1.62
The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod (1999) 1.59
Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy (1993) 1.58
Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition (1997) 1.54
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford) (2008) 1.54
High serum cardiac troponin T concentrations in preterm infants with respiratory distress syndrome. Acta Paediatr (2000) 1.50
Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod (2002) 1.47
Association of keratin 8 gene mutation with chronic pancreatitis. Dig Liver Dis (2003) 1.46
Cardiac screening by STIC: can sonologists performing the 20-week anomaly scan pick up outflow tract abnormalities by scrolling the A-plane of STIC volumes? Ultrasound Obstet Gynecol (2008) 1.44
Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN. J Gastroenterol (1999) 1.44
Non-lipid-related effects of statins. Ann Med (2000) 1.43
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol (1997) 1.42
Upper gastrointestinal injury caused by diquat. Gastrointest Endosc (1992) 1.41
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Int J Biol Markers (2002) 1.40
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series. Ital J Gastroenterol Hepatol (1998) 1.40
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer (1991) 1.39
Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft. Vascular (2011) 1.38
Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. Am J Clin Pathol (1999) 1.38
Neutrophil NADPH oxidase activity in chronic myeloproliferative and myelodysplastic diseases by microscopic and photometric assays. Acta Haematol (1995) 1.37
The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37
Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol (2000) 1.33
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer (2003) 1.30
Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res (1996) 1.28
Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol (2003) 1.23
Direct-to-consumer testing: more risks than opportunities. Int J Clin Pract (2011) 1.22
Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes Care (2000) 1.21
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine (2002) 1.20
Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res (1995) 1.19
Oculovagal reflex in paediatric orbital floor fractures mimicking head injury. Emerg Med J (2009) 1.18
Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem (1989) 1.18
Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis (1998) 1.18
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16
Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis (1987) 1.16
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther (2010) 1.15
Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits. Clin Chem Lab Med (2001) 1.15
Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod (1998) 1.15
Gastric epithelial dysplasia. How clinicopathologic background relates to management. Cancer (1995) 1.13
The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res (1996) 1.13
Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod (2004) 1.13
Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination. J Clin Lab Anal (2001) 1.13
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11
Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci (1996) 1.11
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. Hum Pathol (1991) 1.10
Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem (2000) 1.09
Management of poor responders in IVF. Reprod Biomed Online (2005) 1.09
Brainstem reflex circuits revisited. Brain (2004) 1.09
Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res (2006) 1.09
Relationship between meiotic spindle location with regard to the polar body position and oocyte developmental potential after ICSI. Hum Reprod (2003) 1.08
Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis (2005) 1.07
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy (1995) 1.07
[Is there a role for double-contrast radiology in the characterization of patients with non-ulcer dyspepsia?]. Radiol Med (1991) 1.07
Visceral pain threshold is deeply lowered far from the head in migraine. Headache (1994) 1.06
Laser-evoked potentials as a tool for assessing the efficacy of antinociceptive drugs. Eur J Pain (2009) 1.05
HE4 in ovarian cancer: from discovery to clinical application. Adv Clin Chem (2011) 1.05
Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm (2011) 1.04
Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol (1996) 1.04
An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes. Pancreas (1997) 1.03
Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology (1993) 1.03
Follow-up in gastric dysplasia patients. Am J Surg Pathol (1989) 1.03
The role of cysteine and serine proteases in colorectal carcinoma. Cancer (1999) 1.03
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. Dig Liver Dis (2000) 1.03
Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree. Eur J Clin Invest (1995) 1.02
Rhinocerebral mucormycosis: use of liposomal amphotericin B. J Laryngol Otol (1991) 1.01
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Br J Cancer (1995) 1.01
Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol (1999) 1.01
Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol (1996) 1.01
Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. Anticancer Res (1997) 1.00
Reproductive capacity of spermatozoa from men with testicular failure. Hum Reprod (1999) 1.00